These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22766790)

  • 1. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma.
    Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR
    Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Characteristics and
    Sung JY; Jung YY; Kim HS
    Anticancer Res; 2018 May; 38(5):2779-2786. PubMed ID: 29715099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous morules are functionally inert elements of premalignant endometrial neoplasia.
    Lin MC; Lomo L; Baak JP; Eng C; Ince TA; Crum CP; Mutter GL
    Mod Pathol; 2009 Feb; 22(2):167-74. PubMed ID: 19180120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium.
    Alomari A; Abi-Raad R; Buza N; Hui P
    Mod Pathol; 2014 May; 27(5):675-80. PubMed ID: 24186144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR2 alterations in endometrial carcinoma.
    Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X
    Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary mucinous metaplasia: a distinct precursor of mucinous adenocarcinoma of the endometrium.
    Yoo SH
    Int J Clin Exp Pathol; 2022; 15(2):83-87. PubMed ID: 35265257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
    Nucci MR; Prasad CJ; Crum CP; Mutter GL
    Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging relationships between papillary proliferation of the endometrium and endometrial carcinoma: evidence from an immunohistochemical and molecular analysis.
    Liu Q; Wu Q; Yu M; Shi H; Lu B
    Virchows Arch; 2019 Aug; 475(2):201-209. PubMed ID: 31079233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2-tier subdivision of papillary proliferations of the endometrium (PPE) only emphasizing the complexity of papillae precisely predicts the neoplastic risk and reflects the neoplasia-related molecular characteristics-a single-centered analysis of 207 cases.
    Liu D; Chen T; Yu K; Li J; Wang S; Ma X; Zhu Q; Ning Y; Wang Y
    Virchows Arch; 2022 Oct; 481(4):585-593. PubMed ID: 35796805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation.
    Nicolae A; Preda O; Nogales FF
    J Clin Pathol; 2011 Feb; 64(2):97-106. PubMed ID: 21126963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
    Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
    Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous metaplasia of the endometrium: current concepts.
    Turashvili G; Childs T
    Gynecol Oncol; 2015 Feb; 136(2):389-93. PubMed ID: 25485781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
    Park CK; Yoon G; Cho YA; Kim HS
    Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.
    Ip PP
    Virchows Arch; 2018 Jun; 472(6):907-917. PubMed ID: 29445890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS Mutations in Mucinous Lesions of the Uterus.
    He M; Jackson CL; Gubrod RB; Breese V; Steinhoff M; Lawrence WD; Xiong J
    Am J Clin Pathol; 2015 Jun; 143(6):778-84. PubMed ID: 25972319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.